Found 6 matching trials
Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection
PHASE3The purpose of this study is to evaluate the long term safety and tolerabil...
Location
Multiple Locations
Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase
PHASE2A major factor in the respiratory health of cystic fibrosis (CF) patients i...
Location
Multiple Locations
Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
PHASE3A study to evaluate the effectiveness of Liposomal Amikacin for Inhalation ...
Location
Multiple Locations
Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212
PHASE3This is an open-label safety extension study to assess the safety and toler...
Location
Multiple Locations
Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease
PHASE2The proposed study will assess the efficacy, safety and tolerability of onc...
Location
Oregon Health & Science University
Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria
PHASE2The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Location
Multiple Locations